These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 30300395)

  • 1. Impact of successful treatment with direct-acting antiviral agents on health-related quality of life in chronic hepatitis C patients.
    Juanbeltz R; Martínez-Baz I; San Miguel R; Goñi-Esarte S; Cabasés JM; Castilla J
    PLoS One; 2018; 13(10):e0205277. PubMed ID: 30300395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term changes on health-related quality of life in patients with chronic hepatitis C after viral clearance with direct-acting antiviral agents.
    Goñi Esarte S; Juanbeltz R; Martínez-Baz I; Castilla J; San Miguel R; Herrero JI; Zozaya JM
    Rev Esp Enferm Dig; 2019 Jun; 111(6):445-452. PubMed ID: 31066286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life in hepatitis C patients who achieve sustained virological response to direct-acting antivirals: a comparison with the general population.
    Juanbeltz R; Castilla J; Martínez-Baz I; O'Leary A; Sarobe M; San Miguel R
    Qual Life Res; 2019 Jun; 28(6):1477-1484. PubMed ID: 30666549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of treatment with direct-acting antivirals on anxiety and depression in chronic hepatitis C.
    Gallach M; Vergara M; da Costa JP; Miquel M; Casas M; Sanchez-Delgado J; Dalmau B; Rudi N; Parra I; Monllor T; Sanchez-Lloansí M; Dosal A; Valero O; Calvet X
    PLoS One; 2018; 13(12):e0208112. PubMed ID: 30566421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life in genotype 1 treatment-naïve chronic hepatitis C patients receiving telaprevir combination treatment in the ADVANCE study.
    Vera-Llonch M; Martin M; Aggarwal J; Donepudi M; Bayliss M; Goss T; Younossi Z
    Aliment Pharmacol Ther; 2013 Jul; 38(2):124-33. PubMed ID: 23725204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life and fatigue in patients with chronic hepatitis C with therapy with direct-acting antivirals agents interferon-free.
    Fagundes RN; Ferreira LEVVC; Pace FHL
    PLoS One; 2020; 15(8):e0237005. PubMed ID: 32813740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cross-sectional assessment of health-related quality of life in Chinese patients with chronic hepatitis c virus infection with EQ-5D.
    Huang R; Rao H; Shang J; Chen H; Li J; Xie Q; Gao Z; Wang L; Wei J; Jiang J; Sun J; Jiang J; Wei L
    Health Qual Life Outcomes; 2018 Jun; 16(1):124. PubMed ID: 29903024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained virologic response improved the long-term health-related quality of life in patients with chronic hepatitis C: a prospective national study in China.
    Huang R; Shang J; Chen H; Li J; Xie Q; Feng J; Wei L; Rao H
    BMC Infect Dis; 2024 Jan; 24(1):72. PubMed ID: 38200419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors Associated with Health-Related Quality of Life in Korean Patients with Chronic Hepatitis C Infection Using the SF-36 and EQ-5D.
    Jang ES; Kim YS; Kim KA; Lee YJ; Chung WJ; Kim IH; Lee BS; Jeong SH
    Gut Liver; 2018 Jul; 12(4):440-448. PubMed ID: 29588435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of Life in patients with chronic hepatitis C receiving Sofosbuvir-based treatment, with and without Interferon: a prospective observational study in Egypt.
    Youssef NF; El Kassas M; Farag A; Shepherd A
    BMC Gastroenterol; 2017 Jan; 17(1):18. PubMed ID: 28109264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression of liver fibrosis over a 24-week period after completing direct-acting antiviral therapy in patients with chronic hepatitis C receiving care within the national hepatitis C elimination program in Georgia: results of hepatology clinic HEPA experience.
    Dolmazashvili E; Abutidze A; Chkhartishvili N; Karchava M; Sharvadze L; Tsertsvadze T
    Eur J Gastroenterol Hepatol; 2017 Nov; 29(11):1223-1230. PubMed ID: 28857900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-world impact of direct acting antiviral therapy on health-related quality of life in HIV/Hepatitis C co-infected individuals.
    Saeed S; Moodie EEM; Strumpf E; Gill J; Wong A; Cooper C; Walmsley S; Hull M; Martel-Laferriere V; Klein MB;
    J Viral Hepat; 2018 Dec; 25(12):1507-1514. PubMed ID: 30141236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in Health-related Quality of Life for Hepatitis C Virus-Infected People Who Inject Drugs While on Opioid Agonist Treatment Following Sustained Virologic Response.
    Gormley MA; Akiyama MJ; Rennert L; Howard KA; Norton BL; Pericot-Valverde I; Muench S; Heo M; Litwin AH
    Clin Infect Dis; 2022 May; 74(9):1586-1593. PubMed ID: 34331539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive ability of shear wave elastography for pruritus in chronic hepatitis C patients with sustained virological response.
    Tachi Y; Hirai T; Kojima Y; Ishizu Y; Honda T; Kuzuya T; Hayashi K; Ishigami M; Goto H; Katano Y
    Eur J Gastroenterol Hepatol; 2018 Sep; 30(9):1066-1072. PubMed ID: 29727381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality of life in thrombocytopenic patients with chronic hepatitis C with or without cirrhosis in the ENABLE-1 and ENABLE-2 studies.
    Grotzinger KM; Younossi ZM; Giannini EG; Chen PJ; Rendas-Baum R; Theodore D
    Health Qual Life Outcomes; 2016 Mar; 14():49. PubMed ID: 27004952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus eradication by direct-acting antiviral agents improves carotid atherosclerosis in patients with severe liver fibrosis.
    Petta S; Adinolfi LE; Fracanzani AL; Rini F; Caldarella R; Calvaruso V; Cammà C; Ciaccio M; Di Marco V; Grimaudo S; Licata A; Marrone A; Nevola R; Pipitone RM; Pinto A; Rinaldi L; Torres D; Tuttolomondo A; Valenti L; Fargion S; Craxì A
    J Hepatol; 2018 Jul; 69(1):18-24. PubMed ID: 29505844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A platform in the use of medicines to treat chronic hepatitis C (PLATINUM C): protocol for a prospective treatment registry of real-world outcomes for hepatitis C.
    Ramsay J; Marsh J; Pedrana A; Andric N; Norman R; Cheng W; Webb S; Zeps N; Bellgard M; Graves T; Hellard M; Snelling T
    BMC Infect Dis; 2020 Oct; 20(1):802. PubMed ID: 33121439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life of patients with HIV/AIDS at a tertiary care teaching hospital in Ethiopia.
    Belay YB; Ali EE; Sander B; Gebretekle GB
    Health Qual Life Outcomes; 2021 Jan; 19(1):24. PubMed ID: 33468153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma decreases the chance of successful hepatitis C virus therapy with direct-acting antivirals.
    Prenner SB; VanWagner LB; Flamm SL; Salem R; Lewandowski RJ; Kulik L
    J Hepatol; 2017 Jun; 66(6):1173-1181. PubMed ID: 28161470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of patient-reported outcomes in patients achieving sustained virologic response with direct-acting antivirals for hepatitis C virus infection.
    Yi CH; Bair MJ; Wang JH; Wong MW; Liu TT; Lei WY; Liang SW; Lin L; Hung JS; Huang JF; Hsu YC; Chen CL
    J Microbiol Immunol Infect; 2022 Aug; 55(4):643-650. PubMed ID: 35637143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.